Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Dispositional optimism is unidimensional or bidimensional? The Portuguese revised Life Orientation Test.
Human autoimmunity after lymphocyte depletion is caused by homeostatic T-cell proliferation.
Differential glatiramer acetate treatment persistence in treatment-naive patients compared to patients previously treated with interferon.
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
[Multiple sclerosis : actuality and therapeutic prospects].
Intensive immunosuppression with cyclophosphamide in multiple sclerosis. Follow up of 110 patients for 2-6 years.
Pilates based core stability training in ambulant individuals with multiple sclerosis: Protocol for a multi-centre randomised controlled trial.
Parent-of-origin effect in multiple sclerosis: observations in half-siblings.
Periventricular lesions help differentiate neuromyelitis optica spectrum disorders from multiple sclerosis.
Two Years Follow up of Domain Specific Cognitive Training in Relapsing Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Medicare Part D payments for neurologist-prescribed drugs.
High dose thiamine improves fatigue in multiple sclerosis.
Santhera enters agreement with Columbia University to investigate additional potential of Catena® in MELAS
[Diagnosis of multiple sclerosis - the 2010 revision of the McDonald criteria.]
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients
Amiloride HCI Tablets, USP 5 mg
Receptos provides update on progress of lead product candidate RPC1063
Self-perceived performance and satisfaction with performance of daily activities in persons with multiple sclerosis following interdisciplinary rehabilitation.
Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia.
Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis.
The risk of multiple sclerosis in bereaved parents: A nationwide cohort study in Denmark.
A safety and pharmacokinetic study of intravenous natalizumab in patients with MS.
[Budget impact analysis of the first-line treatment of relapsing remitting multiple sclerosis in Spain. Reply].
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.

Pages